Pacific Biosciences of California, Inc.'s revenue has grown 2.9% a year over three years, and grown 8.9% a year over five. Revenue growth, 3-year annual rate: +2.9% (Medical Devices median +11%). Revenue growth, 5-year rate: +8.9%, growth has slowed since the five-year average. Years of annual history on file: 17, FY2009 to FY2025, as filed.

PACBPacific Biosciences of California, Inc.

Healthcare

$2.11+15% 1Y

$2.11

$1.1152 weeks$2.88

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin widening (+371.9 points).

1 good, 1 neutral, 1 without data

Revenue trend+2% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +9% a year.

Margin direction+371.9 points operating

Trailing-twelve-month operating margin, -82.6% now against -454.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is PACB growing?

Pacific Biosciences of California, Inc.'s revenue has grown 2.9% a year over three years, and grown 8.9% a year over five.

+2.9%

Revenue growth, 3-year annual rate · Medical Devices median +11% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +8.9%
Revenue growth, 5-year rate · +2.9% over three · growth has slowed since the five-year average
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›